Omeros OMER
NASDAQ OMER
$19.13 +0.01 (+0.08%)
As of: Sep 4, 2026 · 3:19 PM EDT

Omeros (OMER) Gross Margin Growth (3y) (2017 - 2021)

Analysis

Omeros (OMER) Gross Margin Growth (3y) (2017 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -168.00
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -65.00
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 14,836.00
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 589.00
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 53.00
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 569.00
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -9,555.00
Sep 30, 2021 -33.00
Jun 30, 2021 582.00
Mar 31, 2021 1,153.00
Dec 31, 2020 256.00
Sep 30, 2020 -69.00
Jun 30, 2020 -17.00
Mar 31, 2020 108.00
Dec 31, 2019 174.00
Sep 30, 2019 242.00
Jun 30, 2019 306.00
Mar 31, 2019 381.00
Dec 31, 2018 553.00
Sep 30, 2018 683.00
Jun 30, 2018 444.00
Mar 31, 2018 -995.00
Dec 31, 2017 -338.00
Sep 30, 2017 -85.00
Jun 30, 2017 -92.00
Mar 31, 2017 -221.00